دورية أكاديمية
Cognitive impairment and associated factors among patients with diabetes mellitus in Africa: a systematic review and meta-analysis.
| العنوان: | Cognitive impairment and associated factors among patients with diabetes mellitus in Africa: a systematic review and meta-analysis. |
|---|---|
| المؤلفون: | Chekol Tassew W; Department of Medical Nursing, Teda Health Science College, Gondar, Ethiopia., Ferede YA; Department of Reproductive Health, Teda Health Science College, Gondar, Ethiopia., Zeleke AM; Department of Clinical Midwifery, Teda Health Science College, Gondar, Ethiopia. |
| المصدر: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jul 17; Vol. 15, pp. 1386600. Date of Electronic Publication: 2024 Jul 17 (Print Publication: 2024). |
| نوع المنشور: | Systematic Review; Meta-Analysis; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
| مواضيع طبية MeSH: | Cognitive Dysfunction*/epidemiology , Cognitive Dysfunction*/etiology , Diabetes Mellitus*/epidemiology, Humans ; Africa/epidemiology ; Risk Factors ; Prevalence ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Complications/epidemiology |
| مستخلص: | Background: Inappropriate management of blood sugar in patients with diabetes mellitus leads to micro-vascular and macro-vascular complications, subsequently leading to high morbidity and mortality rates. In addition, diabetes independently increases the occurrence of cognitive impairment complicated by dementia. Scientific evidence on the magnitude of cognitive impairment will provide a sound basis for the determination of healthcare needs and the planning of effective healthcare services. Despite this, there are no comprehensive data on the prevalence and associated factors of cognitive impairment among patients with diabetes in Africa. Methods: To identify relevant articles for this review, we searched PubMed, Cochrane Library, Science Direct, African Journals Online, and Google Scholar. After extraction, the data were imported into Stata software version 11 (Stata Corp., TX, USA) for further analysis. The random-effects model, specifically the DerSimonian and Laird (D+L) pooled estimation method, was used due to the high heterogeneity between the included articles. Begg's and Egger's regression tests were used to determine the evidence of publication bias. Sub-group analyses and sensitivity analyses were also conducted to handle heterogeneity. Results: The pooled prevalence of cognitive impairment among patients with diabetes in Africa is found to be 43.99% (95% CI: 30.15-57.83, p < 0.001). According to our analysis, primary level of education [pooled odds ratio (POR) = 6.08, 95% CI: 3.57-10.36, I 2 = 40.7%], poorly controlled diabetes mellitus (POR = 5.85, 95% CI: 1.64-20.92, I 2 = 87.8%), age above 60 years old (POR = 3.83, 95% 95% CI: 1.36-10.79, I 2 = 63.7%), and diabetes duration greater than 10 years (POR = 1.13; 95% CI: 1.07-1.19, I 2 = 0.0%) were factors associated with cognitive impairment among patients with diabetes. Conclusion: Based on our systematic review, individuals with diabetes mellitus exhibit a substantial prevalence rate (43.99%) of cognitive impairment. Cognitive impairment was found to be associated with factors such as primary level of education, poorly controlled diabetes mellitus, age above 60 years, and diabetes duration greater than 10 years. Developing suitable risk assessment tools is crucial to address uncontrolled hyperglycemia effectively. Systematic Review Registration: https://www.crd.york.ac.uk/prospero, identifier CRD42024561484. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Chekol Tassew, Ferede and Zeleke.) |
| References: | J Neural Transm (Vienna). 2017 Nov;124(11):1431-1454. (PMID: 28766040) Curr Vasc Pharmacol. 2020;18(2):104-109. (PMID: 30961501) BMJ. 2015 Jan 02;350:g7647. (PMID: 25555855) Cureus. 2022 Aug 23;14(8):e28305. (PMID: 36168366) Ann N Y Acad Sci. 2015 Sep;1353:60-71. (PMID: 26132277) SAGE Open Nurs. 2024 Jan 29;10:23779608241227752. (PMID: 38292043) Arch Gerontol Geriatr. 2016 Jan-Feb;62:138-42. (PMID: 26381432) Am J Pathol. 1998 Oct;153(4):1149-55. (PMID: 9777946) Acta Diabetol. 2021 Jun;58(6):671-685. (PMID: 33417039) J ASEAN Fed Endocr Soc. 2017;32(2):145-150. (PMID: 33442098) Indian J Endocrinol Metab. 2019 May-Jun;23(3):353-356. (PMID: 31641638) Front Aging Neurosci. 2019 Jul 30;11:180. (PMID: 31417393) Bull World Health Organ. 2013 Oct 1;91(10):773-83. (PMID: 24115801) Arch Neurol. 2007 Apr;64(4):570-5. (PMID: 17420320) Stroke. 2003 Feb;34(2):392-6. (PMID: 12574548) Stat Med. 2002 Jun 15;21(11):1539-58. (PMID: 12111919) Community Ment Health J. 2016 May;52(4):479-83. (PMID: 26724818) J Nucl Med. 2014 May;55(5):759-64. (PMID: 24652830) Diabetes Care. 2020 Mar;43(3):683-690. (PMID: 31932459) J Clin Epidemiol. 2012 Sep;65(9):934-9. (PMID: 22742910) Nutr Metab Cardiovasc Dis. 2018 Dec;28(12):1253-1260. (PMID: 30355471) Neurology. 2014 Jan 28;82(4):317-25. (PMID: 24353333) Psychiatry Res. 2012 Mar 30;196(1):90-5. (PMID: 22390831) Alzheimers Dement. 2013 Jan;9(1):63-75.e2. (PMID: 23305823) Diabetes Res Clin Pract. 2019 Nov;157:107843. (PMID: 31518657) J Diabetes Res. 2014;2014:179648. (PMID: 25431771) Endocr Rev. 2008 Jun;29(4):494-511. (PMID: 18436709) Lancet Diabetes Endocrinol. 2014 Mar;2(3):228-35. (PMID: 24622753) WHO South East Asia J Public Health. 2014 Apr-Jun;3(2):135-143. (PMID: 28607299) Diabetol Int. 2016 Nov 01;8(2):193-198. (PMID: 30603321) Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. (PMID: 22079683) Int J Mol Sci. 2022 May 30;23(11):. (PMID: 35682821) J Nucl Cardiol. 2016 Aug;23(4):690-2. (PMID: 26245193) Epidemiol Rev. 2013;35:152-60. (PMID: 23314404) Ann Neurol. 1990 Apr;27(4):428-37. (PMID: 2353798) Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):411-24. (PMID: 23558486) BMC Res Notes. 2019 Aug 15;12(1):510. (PMID: 31416481) Ethn Dis. 2006 Winter;16(1):9-15. (PMID: 16599342) IBRO Neurosci Rep. 2022 Feb 17;12:182-187. (PMID: 35746970) Arch Neurol. 2008 Aug;65(8):1066-73. (PMID: 18695056) |
| فهرسة مساهمة: | Keywords: Africa; cognitive impairment; diabetes mellitus; meta-analysis; systematic review |
| تواريخ الأحداث: | Date Created: 20240801 Date Completed: 20240801 Latest Revision: 20240802 |
| رمز التحديث: | 20240802 |
| مُعرف محوري في PubMed: | PMC11288936 |
| DOI: | 10.3389/fendo.2024.1386600 |
| PMID: | 39086905 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2024.1386600 |